Abstract
Purpose :
Research on therapeutic biomarkers for pterygium is crucial for developing novel therapies. We aimed to analyze the interactions between scientists and journals to show an overview of the state of knowledge in the field by performing a bibliometric analysis of recent scientific articles published in the literature.
Methods :
We conducted a bibliographic search on PubMed, Scopus, and Clarivate databases. Original research articles or reviews mentioning novel biomarkers in the title or abstract published between 2018 and 2022 met our inclusion criteria. Articles referring solely to surgical or adjuvant therapies, special articles, and duplicates were excluded. We created a database with variables such as title, publication year, country, Journal, Quartile, and impact factor. For categorical data, we used descriptive statistics (Data were processed in SPSS, V28). Articles were analyzed using VOS-viewer (1.6.18) to build six bibliometric maps of the most relevant authors, journals, and their interactions using citation and bibliographic coupling as the type of analysis and authors and sources as the unit of analysis.
Results :
We Included 94 articles from 23 countries, 509 authors, 59 journals, 378 citations, and 3,441 references. China (30.9%), Turkey (13.8%), and Taiwan (8.5%) published the most. Publications occurred in 2018 (17%), 2019 (23.4%), 2020 (22.3%), 2021 (12.1%), and 2022 (18.1%). The Journal quartile distribution was: Q1 (43.6%), Q2 (37.2%), Q3 (9.6%), and Q4 (9.5%). The median impact factor (IQR): is 3.1 (1.75). VOS-Viewer citation analysis showed 36 authors and 33 journals citing each other. The bibliographic coupling also found references between 46 authors and 34 journals. Bibliographic coupling analysis showed stronger links. Vishal Jhanji and Wai Kit Chu were the most prolific authors (6 articles with 91 citations; and 5 articles with 83 citations, respectively). IOVS and Exp. Eye Res. were cited the most (Six published articles with 47 citations; and six published articles with 42 citations).
Conclusions :
The research on pterygium therapeutic biomarkers is mainly reported in China, in IOVS, and Exp. Eye Res. journals. In the last two years, article publication has decreased. This analysis demonstrates the current research on pterygium biomarkers, which is important for future directions in the field.
This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.